Latest filing published 17 Oct 2022 for GeneTether Therapeutics Inc., €1,004.
All filings by Daren Graham on record concern GeneTether Therapeutics Inc. Between 21 March 2022 and 14 October 2022, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €1,004). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 17 October 2022 came the latest disclosure, an open-market purchase for €1,004 in GeneTether Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations